S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled

ImExHS Stock Price, News & Analysis (ASX:IME)

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.09 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About ImExHS

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is headquartered in Mascot, Australia.


IME Stock News Headlines

November 29, 2023 | tmcnet.com
Teleradiology Market to Reach $46.7 Billion, Globally, by 2032 at 18.1% CAGR: Allied Market Research
September 5, 2023 | finance.yahoo.com
ImExHS First Half 2023 Earnings: AU$0.055 loss per share (vs AU$0.053 loss in 1H 2022)
December 1, 2023 | Tomorrow Investor (Ad)
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
July 15, 2023 | finance.yahoo.com
Insider Stock Buying Reaches AU$1.1m On ImExHS
July 4, 2023 | uk.finance.yahoo.com
Radiology Services Global Market Report 2023
April 17, 2023 | finance.yahoo.com
ImExHS Limited (ASX:IME) Could Be Riskier Than It Looks
February 4, 2023 | yahoo.com
Bullish insiders at ImExHS Limited (ASX:IME) loaded up on AU$1.1m of stock earlier this year
July 31, 2022 | afr.com
Celsius Resources, Change Financial, Mighty Kingdom in placements
December 1, 2023 | Tomorrow Investor (Ad)
Why Microsoft Just Placed A Huge Bet On Nuclear
Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.
May 4, 2022 | finance.yahoo.com
Health Check: How Prudently Does ImExHS (ASX:IME) Use Debt?
March 19, 2022 | finance.yahoo.com
Multiple insiders bought ImExHS Limited (ASX:IME) stock earlier this year, a positive sign for shareholders
January 19, 2022 | finance.yahoo.com
Breakeven Is Near for ImExHS Limited (ASX:IME)
October 9, 2021 | uk.finance.yahoo.com
Adele credits gruelling gym sessions with helping her to combat anxiety
October 9, 2021 | nz.finance.yahoo.com
INDUS Announces Fiscal 2021 Third Quarter Earnings Call
October 9, 2021 | nz.finance.yahoo.com
Andy Murray Says He's in Hot Water 'at Home' After Wedding Ring Was Stolen While Tied to His Shoes
October 7, 2021 | finance.yahoo.com
Douglas Lingard Is The Independent Non-Executive Director of ImExHS Limited (ASX:IME) And They Just Picked Up 6.6% More Shares
August 12, 2021 | finance.yahoo.com
Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)
July 25, 2021 | msn.com
ASX health stocks: 4D Medical leads after ramping up its game in the US
May 14, 2021 | finance.yahoo.com
Insider Buying: The ImExHS Limited (ASX:IME) Independent Non-Executive Director Just Bought 8.7% More Shares
May 4, 2021 | finance.yahoo.com
ImExHS (ASX:IME) Shareholders Booked A 30% Gain In The Last Year
April 9, 2021 | msn.com
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’
April 2, 2021 | msn.com
ScoPo’s powerplays: Look to Mach7, Volpara and IMEXHS as quarterly reports near
March 4, 2021 | finance.yahoo.com
When Will ImExHS Limited (ASX:IME) Breakeven?
February 14, 2021 | msn.com
ScoPo’s health powerplays: What to look for this earnings season
November 4, 2020 | finance.yahoo.com
What Type Of Shareholders Own The Most Number of ImExHS Limited (ASX:IME) Shares?
October 8, 2020 | ca.finance.yahoo.com
ImExHS Limited (IME.AX)
August 4, 2020 | msn.com
How tech is changing healthcare, and where professional ASX investors are looking
See More Headlines
Receive IME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImExHS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2019
Today
12/01/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
Current Symbol
ASX:IME
CUSIP
N/A
CIK
N/A
Web
imexhs.com
Phone
57 1 316 4890
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,590,000.00
Net Margins
-21.70%
Pretax Margin
N/A
Return on Equity
-22.33%
Return on Assets
-4.87%

Debt

Debt-to-Equity Ratio
5.78
Current Ratio
1.72
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$16.53 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
5.50
Book Value
A$0.40 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
42,610,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.37
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. German Arango
    Co-Founder, CEO, MD & Director
  • Ms. Reena Minhas
    CFO & Company Secretary
  • Dr. Jorge Marin
    Co-Founder & Chief Medical Officer
  • Mr. Andres Vanegas
    Co-Founder & Strategic Accounts Manager
  • Mr. Alexander Sanz
    Co-Founder & CTO
  • Mr. Orlando Joven
    Chief Operating Officer
  • Mr. Juan Sebastian Bonnet
    Head of Sales
  • Mr. Benjamin Brinquis
    Head of Growth

Key Competitors

View All Competitors

Insiders















IME Stock Analysis - Frequently Asked Questions

How were ImExHS's earnings last quarter?

ImExHS Limited (ASX:IME) posted its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter. ImExHS had a negative trailing twelve-month return on equity of 22.33% and a negative net margin of 21.70%.

This page (ASX:IME) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -